Form 4 for ANVS Annovis Bio, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-09-10 · accession 0001104659-25-109904 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-12 | 2025-09-10 | ANVS | Bruck Claudine | Dir | M - OptEx | $0.14 | +7,142 | 13.7K | +109% | +$999.88 |
| D | 2025-11-12 | 2025-09-10 | ANVS | Bruck Claudine | Dir | M - OptEx | $0.00 | -7,142 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-10 | M | A | 7,142 | $0.14 | 13,709 | D | — | — | |
| 2 | Derivative | Option | 2025-09-10 | M | D | 7,142 | $0.00 | 0 | D | $0.14 · 2016-09-18 to 2025-09-18 | 7,142 Common Stock |